ALK and lung cancer: First, the EV-RNA signatures, low EV-miR-21-5p and high miR-486-3p, MEG3 and XIST identified in this study require clinical validation in a larger patient cohort to confirm their prognostic relevance in ALK-translocated lung cancer.